Evidence map›Paper›PMID 40155050›Full record

ArticleLife science alliance2025

Efficient identification of de novo mutations in family trios: a consensus-based informatic approach.

Mariya Shadrina, Özem Kalay, Sinem Demirkaya-Budak, Charles A LeDuc, Wendy K Chung, Deniz Turgut, Gungor Budak, Elif Arslan, Vladimir Semenyuk, Brandi Davis-Dusenbery and 4 more

Abstract read
In one paragraph

Article in Life science alliance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Mariya ShadrinaMindich Child Health and Development Institute and the Department of Genetics and Genomic Sciences, Icahn School of Medicine, New York, NY, USA.
Özem KalayVelsera Inc., Charlestown, MA, USA.
Sinem Demirkaya-BudakVelsera Inc., Charlestown, MA, USA.
Charles A LeDucDepartment of Pediatrics, Columbia University, New York, NY, USA.
Wendy K ChungDepartment of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-3438-5685
Deniz TurgutVelsera Inc., Charlestown, MA, USA.
Gungor BudakVelsera Inc., Charlestown, MA, USA.
Elif ArslanVelsera Inc., Charlestown, MA, USA.
Vladimir SemenyukVelsera Inc., Charlestown, MA, USA.
Brandi Davis-DusenberyVelsera Inc., Charlestown, MA, USA.
Christine E SeidmanDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-6380-1209
H Joseph YostMolecular Medicine Program, University of Utah, Salt Lake City, UT, USA.ORCID 0000-0003-2961-5669
Amit JainVelsera Inc., Charlestown, MA, USA.
Bruce D GelbMindich Child Health and Development Institute and the Department of Genetics and Genomic Sciences, Icahn School of Medicine, New York, NY, USA bruce.gelb@mssm.edu.ORCID 0000-0001-8527-5027

Funding

Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHDU01HL098147 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI NEWBURGER, JANE W., ROBERTS, AMY E · 2009 to 2024
$6.7M
Identifying and applying genetic variation relevant to clinical outcomes for individuals with congenital heart diseaseU01HL153009 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHUNG, WENDY K, GELB, BRUCE D · 2020 to 2024
$2.3M
Bridging the Gap between Genomics and Clinical Outcomes in CHDU01HL128711 · NHLBI · UNIVERSITY OF UTAH · PI TRISTANI-FIROUZI, MARTIN, YANDELL, MARK DOUGLAS · 2020 to 2024
$2.1M
COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
NCATS NIH HHS UL1 TR004419NHLBI NIH HHS U01 HL098147NHLBI NIH HHS U01 HL128711NHLBI NIH HHS U01 HL153009NIH HHS S10 OD026880NIH HHS S10 OD030463
6 · The paper itself

Abstract

Accurate identification of de novo variants (DNVs) remains challenging despite advances in sequencing technologies, often requiring ad hoc filters and manual inspection. Here, we explored a purely informatic, consensus-based approach for identifying DNVs in proband-parent trios using short-read genome sequencing data. We evaluated variant calls generated by three sequence analysis pipelines-GATK HaplotypeCaller, DeepTrio, and Velsera GRAF-and examined the assumption that a requirement of consensus can serve as an effective filter for high-quality DNVs. Comparison with a highly accurate DNV set, validated previously by manual inspection and Sanger sequencing, demonstrated that consensus filtering, followed by a force-calling procedure, effectively removed false-positive calls, achieving 98.0-99.4% precision. At the same time, sensitivity of the workflow based on the previously established DNVs reached 99.4%. Validation in the HG002-3-4 Genome-in-a-Bottle trio confirmed its robustness, with precision reaching 99.2% and sensitivity up to 96.6%. We believe that this consensus approach can be widely implemented as an automated bioinformatics workflow suitable for large-scale analyses without the need for manual intervention, especially when very high precision is valued over sensitivity.

Indexed as

Computational BiologyMutationConsensusGenome, HumanGuidelines as TopicHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNA

Identifiers

PMID40155050
PMCPMC11953573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.